AstraZeneca might develop cancer vaccines, CEO Pascal Soriot says
dlvr.it/TW5w9d
Story Details
| Last Updated | |
| Total Articles | 1 |
Main Topics
substance used to stimulate the production of antibodies and provide immunity against one or several diseases,agent of a disease, its products, or a synthetic substitute
More articles on this subject
Similar to This
Previous
AstraZeneca CEO Pascal Soriot delivers remarks as firm celebrates transfer to NYSE
qz.com/astrazeneca-ceo-pascal-soriot-nyse-transfer
AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success
cnbc.com/2026/06/05/astrazeneca-ceo-says-ai-is-reshaping-drug-development-and-helping-boost-the-odds-of-success.html
AstraZeneca agrees to lower drug prices for Medicaid under Trump administration deal
abcnews.go.com/Politics/wireStory/astrazeneca-agrees-lower-drug-prices-medicaid-trump-administration-126418888
Ministers take note: now is the moment to fight to keep AstraZeneca’s listing in London
theguardian.com/business/nils-pratley-on-finance/2025/jul/29/ministers-now-is-the-moment-to-fight-to-keep-astrazeneca-london-listing
AstraZeneca pledges $50bn investment in the US amid 200% tariff fears: British-Swedish pharmaceutical company AstraZeneca is expanding its presence in the US in ...
euronews.com/business/2025/07/22/astrazeneca-pledges-50bn-investment-in-the-us-amid-200-tariff-fears
AstraZeneca boosts cancer therapies push with $1 billion EsoBiotec buy: Drugmaker AstraZeneca has agreed to buy Belgium-based biotechnology firm EsoBiotec for up ...
reut.rs/41NdKD2
AstraZeneca aims for $80 bln in total revenue by 2030: AstraZeneca aims to grow revenue by about 75% to $80 billion by 2030, it said on Tuesday ...
reuters.com/business/healthcare-pharmaceuticals/astrazeneca-aims-deliver-80-billion-total-revenue-by-2030-2024-05-21/
Key FactsAstraZeneca Aims to Nearly Double Revenues by 2030
May 21, 2024 · Reading time: ~30 sec.
Summary created with AI assistance · Source: theguardian.com
Summary created with AI assistance · Source: theguardian.com
- Britain’s biggest drugmaker, AstraZeneca, aims to achieve $80 billion in revenues by 2030 from treatments for cancer, rare diseases, and other conditions.
- Presenting growth plans to shareholders in Cambridge, England, CEO Pascal Soriot stated that 12 of the 20 new drugs have the potential to generate over $5 billion in annual revenues, including five cancer treatments.
- AstraZeneca has revamped its drugs pipeline and developed a strong portfolio of cancer, cardiovascular, metabolic, respiratory, and rare disease medicines.
- The company announced plans to build a new factory in Singapore for manufacturing a new generation of cancer-killing drugs and is entering the weight-loss drug market with an obesity and diabetes pill licensed from China.
Pharmaceutical industry: Astra-Zeneca takes over cancer specialist Fusion Pharmaceuticals
handelsblatt.com/unternehmen/industrie/pharmaindustrie-astra-zeneca-uebernimmt-krebsspezialisten-fusion-pharmaceuticals/100025539.html
AstraZeneca targets 2024 growth but mixed views hit shares: AstraZeneca (AZN.L) expects to boost 2024 revenue and profit on the back of its blockbuster cancer ...
reuters.com/business/healthcare-pharmaceuticals/astrazeneca-sees-higher-annual-revenue-profit-2024-02-08/
/cloudfront-us-east-2.images.arcpublishing.com/reuters/R7JPLAI6MJIGBJRFBETHJ32CKY.jpg)
AstraZeneca no longer pursuing U.S. approval for COVID vaccine: AstraZeneca (AZN.L) is no longer pursuing U.S. approval of its COVID-19 vaccine ...
reuters.com/business/healthcare-pharmaceuticals/astrazeneca-withdraws-us-application-covid-vaccine-2022-11-10/
AstraZeneca boss: I don't think I would do anything differently: Pascal Soriot was knighted in the Queen’s Jubilee birthday honours for his contributions to ...
bbc.com/news/business-61671715
AstraZeneca to book modest profit from coronavirus vaccine: British-Swedish pharmaceutical company AstraZeneca says it will start to book a modest profit from ...
abcnews.go.com/Health/wireStory/astrazeneca-book-modest-profit-coronavirus-vaccine-81126754
AstraZeneca to take profits from Covid vaccine: The drugs giant signs new deals, but poorer countries will continue to get the vaccine at cost price.
bbc.com/news/business-59256223
May was biggest month for Costa Rica visitors since pandemic began -: Costa Rica welcomed more than 90,000 international travelers in May, the largest ...
ticotimes.net/2021/06/08/may-was-biggest-month-for-costa-rica-visitors-since-pandemic-began
AstraZeneca chief hits back at ‘armchair generals’ after criticism: Pascal Soriot defends firm and says its booster jab has performed well against new Covid ...
theguardian.com/business/2021/may/22/astrazeneca-chief-hits-back-at-armchair-generals-after-criticism
We didn't overpromise Covid-19 vaccine supply: AstraZeneca CEO Pascal Soriot: AstraZeneca Chief Executive Pascal Soriot said on Friday the drugmaker had not ...
deccanherald.com/international/world-news-politics/we-didnt-overpromise-covid-19-vaccine-supply-astrazeneca-ceo-pascal-soriot-980847.html
Bangladesh vaccinates sex workers at largest brothel: It has so far vaccinated nearly 3 million people aged 40 or above with the AstraZeneca jab ...
news.abs-cbn.com/overseas/02/25/21/bangladesh-vaccinates-sex-workers-at-largest-brothel
Coronavirus: AstraZeneca defends EU vaccine rollout plan: The pharmaceutical giant said the late signing of contracts limited time to sort out supply glitches.
bbc.com/news/world-europe-55817633
AstraZeneca Hits Back At EU Accusation It’s Backtracking On Its Covid-19 Vaccine Contract
forbes.com/sites/roberthart/2021/01/27/astrazeneca-hits-back-at-eu-accusation-its-backtracking-on-its-covid-19-vaccine-contract/
Paid articlePaywall Next